A Risk Assessment Tool to Increase Statin Use Among High Risk Cancer Survivors: Development and Pilot Testing

Memorial Sloan Kettering Cancer Center (MSK)

Status: Completed

Conditions: Cancer Survivors; Statin Use Among High Risk Survivors

Treatments: Behavioral: usual care; Behavioral: statin communication tool

Study type: Observational

Funder types: Other

Identifiers

NCT02895880

16-1128

Details and patient eligibility

About

The purpose of this study is to collect initial data on what survivors of childhood, adolescent, and young adult cancer think of how information about statins is communicated. Statins are medications that lower cholesterol. The results of this study will be used to improve the communication about statins. This is to aid patients and their providers in making health care decisions together, also known as shared decision making.

Enrollment: 49 patients

Sex: All

Ages: 25+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• English speaking
• A personal history of cancer, tumor, or a related illness
• Followed in the Adult Long Term Follow Up Program
• Received ≥ 2000 cGy radiation to the heart/chest
• ≥Ten years post-radiation therapy to the heart/chest
• Age ≥ 25 years old

Exclusion criteria

• Evidence of active progression of disease or recurrence
• Neurocognitive deficits that impair ability to give informed consent
• Current use of a statin
• Diagnosis of another primary cancer for which the patient is currently undergoing radiation therapy chemotherapy, or bone marrow transplant
• Diagnosis of CVD with or without current statin use

Trial design

49 participants in 2 patient groups

usual care

Description:

first 25 participants will receive usual care (i.e. no risk communication tool)

Treatment:

Behavioral: usual care

risk communication tool

Description:

next 25 participants, clinicians will use the risk communication tool in their discussion about statins and cardiovascular risk reduction

Treatment:

Behavioral: statin communication tool